apalutamide 240 MG Oral Tablet

RxCUI: 2630215
RxNorm name: apalutamide 240 MG Oral Tablet
Display name: apalutamide 240 MG Oral Tablet
Full name: apalutamide 240 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ERLEADA	APALUTAMIDE	Janssen Products, LP	d1cda4f7-cb33-46ea-b9ac-431f6452b1a5	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 2630215

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d1cda4f7-cb33-46ea-b9ac-431f6452b1a5	apalutamide 240 MG Oral Tablet	SCD	28	These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018	20260310
d1cda4f7-cb33-46ea-b9ac-431f6452b1a5	apalutamide 240 MG Oral Tablet	PSN	28	These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018	20260310